Summary:
This is an eczema study seeing to assess the efficacy and safety of an orally administered drug for patients with Atopic Dermatitis (Eczema). Over the course of 10 weeks the patient will be asked to visit the clinic 5 times on a bi-weekly basis. Each visit lasts for 30-90 minutes.
Qualified Participants Must:
• Be patients with active Eczema
•
Be patients whose pre-study clinical laboratory findings do not interfere with their participation in the study, in the opinion of the invstigator
•
Be 18 years of age or older
Qualified Participants May Receive:
- $50 per visit for time and travel
- Treatment of eczema
- Free evaluation, treatment and medication relating to Atopic Dermatitis for the duration of the study.